Circassia Pharmaceuticals Plc Total Voting Rights Update (1686V)

TIDMCIR

RNS Number : 1686V

Circassia Pharmaceuticals Plc

31 October 2017

For immediate release

Circassia Pharmaceuticals plc

Total Voting Rights Update

31(st) October 2017

In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) confirms that the Company's issued share capital consists of 333,466,262 ordinary shares of 0.08p each in issue, each with equal voting rights. No shares are held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure and Transparency Rules.

-Ends-

 
 For further information, please contact: 
 
   Circassia Pharmaceuticals plc        +44 (0) 1865 
   Julien Cotta, Company Secretary      405560 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRBRBDGLBXBGRB

(END) Dow Jones Newswires

October 31, 2017 13:18 ET (17:18 GMT)